Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Breast Cancer Risk Reduction and Early Detection, PDF eBook

Breast Cancer Risk Reduction and Early Detection PDF

Edited by Edward R. Sauter, Mary B. Daly

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

While many comprehensive texts have been written on the treatment of breast cancer, the most common cancer among women, there are relatively few which cover in depth the prevention and early detection of the disease.

The goal of this work is to present what experts in the ?eld feel is the current knowledge and future direction of breast cancer prevention and early detection.

We begin Part I of the book with a review of risk factors, both genetic and environmental.

We next review progress in the use of chemoprevention.

Notably, chemoprevention risk reduction studies have led to FDA approval of two medications which measurably reduce disease incidence among women at increased risk, although with some risk of treatment related side effects.

Newer agents in the pipeline, which may also reduce risk among normal risk women, are also discussed.

Surgical risk reducing strategies complete the section on prevention, including both the bene?ts and downsides to this more aggressive approach.

Even with aggressive prevention strategies, some women will develop breast cancer.

For these women, early detection is critical to minimize disease spread and maximize long term survival.

Part II of this book reviews current and upcoming approaches to early detection.

Imaging strategies, including mammography, breast ultrasound, MRI, and PET imaging are reviewed.

The potential for molecular tumor targeting to detect disease prior to the formation of a mass visible by anatomic imaging is presented.

Information

Information